Geneos Wealth Management’s Cellcom Israel, Ltd. CEL Stock Holding History

Geneos Wealth Management’s Portfolio CEL Stock Details CEL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-400	Closed	-$1K	–	2712
2020 Q2	$1K	Hold	400	–	–	﹤0.01%	2551
2020 Q1	$1K	Hold	400	–	–	﹤0.01%	2462
2019 Q4	$1K	Hold	400	–	–	﹤0.01%	2534
2019 Q3	$1K	Hold	400	–	–	﹤0.01%	2476
2019 Q2	$1K	Hold	400	–	–	﹤0.01%	2480
2019 Q1	$1K	Hold	400	–	–	﹤0.01%	2391
2018 Q4	$2K	Hold	400	–	–	﹤0.01%	2262
2018 Q3	$2K	Hold	400	–	–	﹤0.01%	2306
2018 Q2	$2K	Hold	400	–	–	﹤0.01%	2157
2018 Q1	$2K	Hold	400	–	–	﹤0.01%	2080
2017 Q4	$4K	Hold	400	–	–	﹤0.01%	1913
2017 Q3	$2K	Hold	400	–	–	﹤0.01%	2019
2017 Q2	$3K	Hold	400	–	–	﹤0.01%	1893
2017 Q1	$4K	Hold	400	–	–	﹤0.01%	1779
2016 Q4	$3K	Hold	400	–	–	﹤0.01%	1813
2016 Q3	$2K	Hold	400	–	–	﹤0.01%	1837
2016 Q2	$2K	Hold	400	–	–	﹤0.01%	1718
2016 Q1	$2K	Buy	+400	New	+$2.53K	﹤0.01%	1704

Other funds holding CEL

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

MetLife New York $12.3M AUM 29% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Altshuler Shaham Tel Aviv, Israel $5.54B AUM 44.68% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

MIH

Meitav Investment House Bene-Beraq, Israel $9.12B AUM 42.07% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return

Swiss National Bank Zurich, Switzerland $174B AUM 30.96% 1-Year Est. Return

Geneos Wealth Management's CEL Position: Q3 2020 in Review

Geneos Wealth Management sold out of Cellcom Israel, Ltd. (CEL) in Q3 2020, closing a stake of 400 shares — an estimated $1K sold.

Geneos Wealth Management first reported a position in CEL in Q1 2016 and held it in 18 quarters. The position peaked at $4K in Q4 2017. 34 funds tracked by Wall St. Rank hold CEL as of Q3 2020.

Geneos Wealth Management reported no remaining Cellcom Israel, Ltd. position as of Q3 2020 after selling out during the quarter.
Geneos Wealth Management sold 400 Cellcom Israel, Ltd. shares in Q3 2020, an estimated $1K.
Geneos Wealth Management first reported a position in Cellcom Israel, Ltd. in Q1 2016 and held it in 18 quarters.
Geneos Wealth Management's Cellcom Israel, Ltd. position peaked at $4K in Q4 2017.
34 funds tracked by Wall St. Rank held Cellcom Israel, Ltd. as of Q3 2020.

Based on Geneos Wealth Management's 13F filing for Q3 2020, filed 7 Sep 2021.